Obstructive sleep apnea: Proposed scoring system.
Level 5 - mechanism / opinion, no new human data
Proposed clinical screening tool without reported empirical validation data.
PubMed 42058798 · doi:10.5662/wjm.v16.i2.114192
What was done
The authors proposed a 3-question clinical screening tool intended to identify individuals at risk for obstructive sleep apnea. No clinical validation design, study cohort, or testing methodology is described in the abstract.
What was found
The abstract reports that 80% of obstructive sleep apnea cases remain undiagnosed and contribute to sudden death. No quantitative validation metrics (such as sensitivity, specificity, predictive values, or area under the curve) are reported for the proposed 3-question tool.
Why it matters
A short 3-question instrument could lower the barrier to screening for obstructive sleep apnea in routine clinical settings if shown to be diagnostically accurate.
Limits
The abstract provides no empirical test data, sample size, comparator reference standard (such as polysomnography), or statistical performance measures. The three specific questions forming the screening tool are also not detailed in the abstract.
Cited by
- supports Between 70% and 80% of sleep disorders go undiagnosed.